Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Sexual Health Reports
Erschienen in: Current Sexual Health Reports 4/2018

07.09.2018 | Clinical Therapeutics (B McCarthy and RT Segraves, Section Editors)

A Review of Recent Innovations in the Treatment of Low Sexual Desire

Erschienen in: Current Sexual Health Reports | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To review approaches since 2013 of the clinical management of low sexual desire.

Recent Findings

The history of the treatment of the sexual dysfunctions has emphasized that the couple should be the target of treatment. Recent attempts at treatment of low desire have focused on women rather than couples. Men with low desire or couples with sexual desire discrepancies are generally overlooked. Among pharmaceutical interventions, only flibanserin (Addyi) has been approved by the FDA for treatment of low desire in premenopausal women. Other treatments for low desire in women include bibliotherapy and mindfulness. Models of couples therapy tend to focus on sexual desire discrepancies or enhancing the quality of erotic intimacy within relationships rather than treating the identified patient.

Summary

There is a lack of consensus as to how to conceptualize and how to treat low sexual desire in men, women, or couples and on whether to target the identified patient or the relationship.
Literatur
1.
Leiblum SR. Introduction and overview: clinical perspectives on and treatment for sexual desire disorders. In: Leiblum SR, editor. Treating sexual desire disorders: a clinical casebook. New York: Guilford; 2010. p. 1–22.
2.
Masters WH, Johnson VE. Human sexual inadequacy. New York: Bantam Books; 1970.
3.
Kaplan HS. Hypoactive sexual desire. J Sex Marital Ther. 1977;3(1):3–9.CrossRef
4.
Lief HI. Inhibited sexual desire. Med Aspects Hum Sex. 1977;7:94–5.
5.
• Kleinplatz PJ, Paradis N, Charest M, Lawless S, Neufeld M, Neufeld R, et al. From sexual desire discrepancies to desirable sex: creating the optimal connection. J Sex Marital Ther. 2017 Nov 21 [cited 2018 Jul 19]. https://​doi.​org/​10.​1080/​0092623X.​2017.​1405309. This article provides data on the efficacy of a group couples’ sex therapy trial to improve low desire/frequency and sexual desire discrepancies in couples.
6.
•• McCarthy B, Koman CA, Cohn D. A psychobiosocial model for assessment, treatment, and relapse prevention for female sexual interest/arousal disorder. Sex Relation Ther. 2018 May 2 [cited 2018 Jul 19]. https://​doi.​org/​10.​1080/​14681994.​2018.​1462492.This paper highlights the importance of taking an integrative, couple psychobiosocial approach in the treatment of desire problems in women.
7.
McCarthy B, McCarthy E. Rekindling desire: a step-by-step program to help low-sex and no-sex marriages. New York: Routledge; 2014.
8.
Schnarch D. Passionate marriage: love, sex, and intimacy in emotionally committed relationships. New York: Wiley; 2009.
9.
Weeks GR, Gambescia N, Hertlein KM. A clinician’s guide to systemic sex therapy. New York: Routledge; 2016.
10.
Meixel A, Yanchar E, Fugh-Berman A. Hypoactive sexual desire disorder: inventing a disease to sell low libido. J Med Ethics. 2015;41:859–62.CrossRef
11.
Moynihan R, Mintzes B. Sex, lies and pharmaceuticals: how drug companies plan to profit from female sexual dysfunction. Vancouver: Greystone Books; 2010.
12.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington: APA; 2013.CrossRef
13.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington: APA; 1980.
14.
Lewis RW, Fugl-Meyer KS, Corona G, Hayes RD, Laumann EO, Moreira ED Jr, et al. Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med. 2010;7:1598–607.CrossRef
15.
West SL, D’Aloisio AA, Agans RP, Kalsbeek WD, Borisov NN, Thorp JM. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med. 2008;168(13):1441–9.CrossRef
16.
McCarthy B, McDonald OD. Psychobiosocial versus biomedical models of treatment: semantics or substance. Sex Relation Ther. 2009;24:30–7.CrossRef
17.
Heiman J. Sexual dysfunction: overview of prevalence, etiological factors, and treatment. J Sex Res. 2002;39(1):73–8.CrossRef
18.
Kaplan HS. The new sex therapy. New York: Brunner/Mazel; 1977.
19.
Kleinplatz PJ. Optimal erotic intimacy: lessons from great lovers. In: Levine S, Althof N, Risen C, editors. Handbook of clinical sexuality for mental health professionals. 3rd ed. New York: Routledge; 2016. p. 318–30.
20.
Shaw J. Approaching your highest sexual function in relationship: a reward of age and maturity. In: Kleinplatz PJ, editor. New directions in sex therapy: innovations and alternatives. 2nd ed. New York: Routledge; 2012. p. 175–94.
21.
Tuiten A, van Rooij K, Bloemers J, Eisenegger C, van Honk J, Kessels R, et al. Efficacy and safety of on-demand use of 2 treatments designed for different etiologies of female sexual interest/arousal disorder: 3 randomized clinical trials. J Sex Med. 2018;15:201–16.CrossRef
22.
Kleinplatz PJ. Arousal and desire problems: conceptual, research and clinical considerations or the more things change the more they stay the same. Sex Relation Ther. 2011;26(1):3–15.CrossRef
23.
• Althof SE, Needle RB. Treating low desire in men. In: Peterson ZD. The Wiley handbook of sex therapy. New Jersey: Wiley; c2017. p. 32–39. This chapter provides the most recent clinical guidelines for treating low desire in men. CrossRef
24.
Rubio-Aurioles E, Bivalacqua TJ. Standard operational procedures for low sexual desire in men. J Sex Med. 2013;10:94–107.CrossRef
25.
Anderson RC, Moffatt CE. Ignorance is not bliss: if we don’t understand hypoactive sexual desire disorder, how can flibanserin treat it? Commentary. J Sex Med. 2018;15:273–83.CrossRef
26.
• Weinberger JM, Houman J, Caron AT, Patel DN, Baskin AS, Ackerman AL, et al. Female sexual dysfunction and the placebo effect: a meta-analysis. Obstet Gynecol. 2018 Jul 10 [cited 2018 Jul 25]. https://​doi.​org/​10.​1097/​AOG.​0000000000002733​. This article points to the high rates of placebo effects in clinical research on female sexual dysfunctions. CrossRef
27.
Stahl SM. Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder. CNS Spectr. 2015;20:1–6.CrossRef
28.
Gao Z, Diandong Y, Luxin Y, Cui Y. Efficacy and safety of flibanserin in women with hypoactive sexual desire disorder: a systematic review and meta-analysis. J Sex Med. 2015;12:2095–104.CrossRef
29.
• Jaspers L, Feys F, Bramer WM, Franco OH, Leusink P, ETM L. Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: a systematic review and meta-analysis. JAMA Intern Med. 2016;176(4):453–62. This robust review found flibanserin to be no more effective than placebo in increasing women’s sexual desire based on published and unpublished clinical trial data. CrossRef
30.
• Saadat SH, Kabir A, Rahmani K, Panahi Y, Hosseinialhashemi M, Sahebkar A. Systematic review and meta-analysis of flibanserin’s effects and adverse events in women with hypoactive sexual desire disorder. Curr Drug Metab. 2017;18(1):78–85. This review found flibanserin to be no more effective than placebo in increasing women’s sexual desire. CrossRef
31.
32.
Brotto LA, Basson R. Group mindfulness-based therapy significantly improves sexual desire in women. Behav Res Ther. 2014;57:43–54.CrossRef
33.
• Paterson LQP, Handy AB, Brotto LA. A pilot study of eight-session mindfulness-based cognitive therapy adapted for women’s sexual interest/arousal disorder. J Sex Res. 2017;54(7):850–61. This study piloted at an eight-week, mindfulness-based cognitive behavioral therapy intervention to improve low desire in women. CrossRef
34.
Mintz LA. Tired woman’s guide to passionate sex. Avon: Adam’s Media; 2009.
35.
Hall K. Reclaiming your sexual self: how you can bring desire back into your life. Hoboken: Wiley; 2004.
36.
Balzer AM, Mintz LB. Comparing two books and establishing probably efficacious treatment for low sexual desire. J Couns Psychol. 2015;62(2):321–8.CrossRef
37.
Mintz LB, Balzer AM, Zhao X, Bush HE. Bibliotherapy for low sexual desire: evidence for effectiveness. J Couns Psychol. 2012;59(3):471–8.CrossRef
38.
Pellow J, McGrath L. Herbal medicine for low sexual desire in menopausal women: a clinical review. Complement Ther Clin Pract. 2016;25:122–9.CrossRef
39.
Kleinplatz PJ, Ménard AD, Paquet M, Paradis N, Campbell M, Zuccarino D, et al. The components of optimal sexuality: a portrait of “great sex”. Can J Hum Sex. 2009;18(1–2):1–13.
40.
Clayton AH, Althof SE, Kingsberg S, DeRogatis LR, Kroll R, Goldstein I, et al. Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial. Womens Health. 2016;12(3):325–37.
41.
de Araujo AC, da Silva FG, Salvi F, Awad MC, da Silva EA, Damião R. The management of erectile dysfunction with placebo only: does it work? J Sex Med. 2009 Dec;6(12):3440–8.CrossRef
Metadaten
Titel
A Review of Recent Innovations in the Treatment of Low Sexual Desire
Publikationsdatum
07.09.2018
Erschienen in
Current Sexual Health Reports / Ausgabe 4/2018
Print ISSN: 1548-3584
Elektronische ISSN: 1548-3592
DOI
https://doi.org/10.1007/s11930-018-0171-4

Weitere Artikel der Ausgabe 4/2018

Current Sexual Health Reports 4/2018 Zur Ausgabe

Male and Female Surgical Interventions (A Burnett and C Carson, Section Editors)

Spermatic Cord Denervation for Chronic Orchialgia

Female Sexual Dysfunction and Disorders (T Lorenz and R Nappi, Section Editors)

Sexual Desire in Women According to Reproductive Milestones

Sexual Orientation and Identity (E Coleman and J Vencill, Section Editors)

An Updated Review of the Literature on LGBTQ+ Intimate Partner Violence

Preclinical and Psychophysiology (F Guaracci and L Marson, Section Editors)

Vocal Signals of Sexual Motivation in Male and Female Rodents

Male Sexual Dysfunction and Disorders (A Pastuszak and N Gupta, Section Editors)

Penile Rehabilitation: the “Up”-date

Male and Female Surgical Interventions (A Burnett and C Carson, Section Editors)

Current Concepts in Scrotal Reconstructive Surgery

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise